Search
for
Sort by
Research 31–60 of 1000+
- Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne
- Treatment of female pattern hair loss with the androgen receptor antagonist flutamide
- Oral Contraceptives and Cyproterone Acetate in Female Acne Treatment
- A Review of hormone-based therapies to treat adult acne vulgaris in women
- Becker's Nevus with Ipsilateral Breast Hypoplasia: Improvement with Spironolactone
- Polycystic ovarian syndrome
- Pharmacological Approaches to Controlling Cardiometabolic Risk in Women with PCOS
- Frontal fibrosing alopecia: Regrowth following cessation of sunscreen on the forehead
- Cross-species sensitivity to a novel androgen receptor agonist of potential environmental concern, spironolactone
- Hormonal therapies for hidradenitis suppurativa: Review
- Hormone therapy in acne
- Provision of Patient‐Centered Transgender Care
- Interaction of spironolactone with rat skin androgen receptor
- The Use of Hormonal Antiandrogen Therapy in Female Patients with Acne: A 10-Year Retrospective Study
- The Hirsute Woman: Challenges in Evaluation and Management
- Contraceptive use in acne
- Hair regrowth in a male patient with extensive androgenetic alopecia on estrogen therapy
- Spironolactone‐induced hepatitis
- Spironolactone in the Treatment of Hirsutism
- Top Ten List of Clinical Pearls in the Treatment of Acne Vulgaris
- Menopausal Acne – Challenges And Solutions
- The use of hormonal agents in the treatment of acne
- Association of Spironolactone Use With Risk of Cancer
- Long-Term Response of Hirsutism and Other Hyperandrogenic Symptoms to Combination Therapy in Polycystic Ovary Syndrome
- Erosive Pustular Dermatosis of the Scalp Induced by Imiquimod
- The Acute Anticonvulsant Effects of Deoxycorticosterone in Developing Rats: Role of Metabolites and Mineralocorticoid‐receptor Responses
- Medical treatment regimens of hirsutism
- Comparison of spironolactone and spironolactone plus finasteride in the treatment of hirsutism
- The Utility of Monitoring Potassium in Transgender, Gender Diverse, and Nonbinary Individuals on Spironolactone
- Spironolactone May be a Cause of Hormonally Associated Vestibulodynia and Female Sexual Arousal Disorder